Identification of B-cell epitopes on virus-like particles of cutaneous alpha-human papillomaviruses

Journal of Virology

Volumn 83, Issue 24, 2009, Pages 12692-12701

  Senger, Tilo ^a   Becker, Maria R ^b   Schädlich, Lysann ^a   Waterboer, Tim ^a   Gissmann, Lutz ^a,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; IMMUNOLOGICAL ADJUVANT; MONOCLONAL ANTIBODY; WART VIRUS VACCINE;

ALPHA HUMAN PAPILLOMAVIRUS; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HUMAN PAPILLOMAVIRUS TYPE 2; HUMAN PAPILLOMAVIRUS TYPE 27; HUMAN PAPILLOMAVIRUS TYPE 57; IMMUNIZATION; IMMUNOREACTIVITY; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; VIRION; VIRUS CAPSID; VIRUS NEUTRALIZATION; VIRUS PARTICLE; WART VIRUS;

ANIMALS; ANTIBODIES, MONOCLONAL; CAPSID PROTEINS; CELL LINE; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; HUMANS; IMMUNIZATION; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; SKIN; VIRION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; MIRIDAE; PAPILLOMAVIRIDAE;

EID: 72849121998     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01582-09     Document Type: Article

References (58)

1. Akgul, B., J. C. Cooke, and A. Storey. 2006. HPV-associated skin disease. J. Pathol. 208:165-175.
2. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
3. Bryan, J. T. 2007. Developing an HPV vaccine to prevent cervical cancer and genital warts. Vaccine 25:3001-3006. (Pubitemid 46482731)
4. Buck, C. B., D. V. Pastrana, D. R. Lowy, and J. T. Schiller. 2004. Efficient intracellular assembly of papillomaviral vectors. J. Virol. 78:751-757.
5. Buck, C. B., and C. D. Thompson. 2007. Production of papillomavirus-based gene transfer vectors. Curr. Protoc. Cell Biol. 37:26.1.1-26.1.19.
6. Buck, C. B., C. D. Thompson, J. N. Roberts, M. Muller, D. R. Lowy, and J. T. Schiller. 2006. Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog. 2:e69.
7. Carter, J. J., G. C. Wipf, S. F. Benki, N. D. Christensen, and D. A. Galloway. 2003. Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1. J. Virol. 77:11625-11632. (Pubitemid 37271661)
8. Casabonne, D., K. M. Michael, T. Waterboer, M. Pawlita, O. Forslund, R. D. Burk, R. C. Travis, T. J. Key, and R. Newton. 2007. A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition. Int. J. Cancer 121:1862-1868.
9. Chan, S. Y., S. H. Chew, K. Egawa, E. I. Grussendorf-Conen, Y. Honda, A. Rubben, K. C. Tan, and H. U. Bernard. 1997. Phylogenetic analysis of the human papillomavirus type 2 (HPV-2), HPV-27, and HPV-57 group, which is associated with common warts. Virology 239:296-302.
10. Chen, X. S., G. Casini, S. C. Harrison, and R. L. Garcea. 2001. Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1. J. Mol. Biol. 307:173-182.
11. Chen, X. S., R. L. Garcea, I. Goldberg, G. Casini, and S. C. Harrison. 2000. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol. Cell 5:557-567. (Pubitemid 30950045)
12. Christensen, N. D., N. M. Cladel, C. A. Reed, L. R. Budgeon, M. E. Embers, D. M. Skulsky, W. L. McClements, S. W. Ludmerer, and K. U. Jansen. 2001. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types. Virology 291:324-334.
13. Christensen, N. D., J. Dillner, C. Eklund, J. J. Carter, G. C. Wipf, C. A. Reed, N. M. Cladel, and D. A. Galloway. 1996. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology 223:174-184.
14. Christensen, N. D., R. Hopfl, S. L. DiAngelo, N. M. Cladel, S. D. Patrick, P. A. Welsh, L. R. Budgeon, C. A. Reed, and J. W. Kreider. 1994. Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein viruslike particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies. J. Gen. Virol. 75(Pt. 9):2271-2276.
15. Christensen, N. D., R. Kirnbauer, J. T. Schiller, S. J. Ghim, R. Schlegel, A. B. Jenson, and J. W. Kreider. 1994. Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology 205:329-335.
16. Christensen, N. D., J. W. Kreider, N. M. Cladel, S. D. Patrick, and P. A. Welsh. 1990. Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11. J. Virol. 64:5678-5681. (Pubitemid 20364570)
17. Christensen, N. D., C. A. Reed, N. M. Cladel, K. Hall, and G. S. Leiserowitz. 1996. Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to typespecific epitopes on HPV-6. Virology 224:477-486.
18. Clifford, G. M., J. S. Smith, T. Aguado, and S. Franceschi. 2003. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br. J. Cancer 89:101-105. (Pubitemid 36897943)
19. Combita, A. L., A. Touze, L. Bousarghin, N. D. Christensen, and P. Coursaget. 2002. Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses. J. Virol. 76:6480-6486.
20. Davidson, E. J., P. Sehr, R. L. Faulkner, J. L. Parish, K. Gaston, R. A. Moore, M. Pawlita, H. C. Kitchener, and P. L. Stern. 2003. Human papillomavirus type 16 E2- and L1-specific serological and T-cell responses in women with vulval intraepithelial neoplasia. J. Gen. Virol. 84:2089-2097.
21. de Villiers, E. M., C. Fauquet, T. R. Broker, H. U. Bernard, and H. zur Hausen. 2004. Classification of papillomaviruses. Virology 324:17-27.
22. Dillner, J., L. Dillner, G. Utter, C. Eklund, A. Rotola, S. Costa, and D. DiLuca. 1990. Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames. Int. J. Cancer 45:529-535. (Pubitemid 20087204)
23. Garcia-Pineres, A., A. Hildesheim, L. Dodd, T. J. Kemp, M. Williams, C. Harro, D. R. Lowy, J. T. Schiller, and L. A. Pinto. 2007. Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 virus-like particles. Clin. Vaccine Immunol. 14:984-989.
24. Harper, D. M., E. L. Franco, C. M. Wheeler, A. B. Moscicki, B. Romanowski, C. M. Roteli-Martins, D. Jenkins, A. Schuind, S. A. Costa Clemens, and G. Dubin. 2006. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367:1247-1255.
25. Harwood, C. A., and C. M. Proby. 2002. Human papillomaviruses and nonmelanoma skin cancer. Curr. Opin. Infect. Dis. 15:101-114.
26. Heim, K., N. D. Christensen, R. Hoepfl, B. Wartusch, G. Pinzger, A. Zeimet, P. Baumgartner, J. W. Kreider, and O. Dapunt. 1995. Serum IgG, IgM, and IgA reactivity to human papillomavirus types 11 and 6 virus-like particles in different gynecologic patient groups. J. Infect. Dis. 172:395-402.
27. Kirnbauer, R., F. Booy, N. Cheng, D. R. Lowy, and J. T. Schiller. 1992. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 89:12180-12184.
28. Kohler, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497.
29. Leigh, I. M., and M. T. Glover. 1995. Cutaneous warts and tumours in immunosuppressed patients. J. R. Soc. Med. 88:61-62.
30. Li, M., P. Beard, P. A. Estes, M. K. Lyon, and R. L. Garcea. 1998. Intercapsomeric disulfide bonds in papillomavirus assembly and disassembly. J. Virol. 72:2160-2167. (Pubitemid 28100772)
31. Ludmerer, S. W., D. Benincasa, and G. E. Mark III. 1996. Two amino acid residues confer type specificity to a neutralizing, conformationally dependent epitope on human papillomavirus type 11. J. Virol. 70:4791-4794.
32. Ludmerer, S. W., D. Benincasa, G. E. Mark III, and N. D. Christensen. 1997. A neutralizing epitope of human papillomavirus type 11 is principally described by a continuous set of residues which overlap a distinct linear, surface-exposed epitope. J. Virol. 71:3834-3839.
33. Ludmerer, S. W., W. L. McClements, X. M. Wang, J. C. Ling, K. U. Jansen, and N. D. Christensen. 2000. HPV11 mutant virus-like particles elicit immune responses that neutralize virus and delineate a novel neutralizing domain. Virology 266:237-245.
34. Matsuura, Y., R. D. Possee, H. A. Overton, and D. H. Bishop. 1987. Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J. Gen. Virol. 68(Pt. 5):1233-1250.
35. McClements, W. L., X. M. Wang, J. C. Ling, D. M. Skulsky, N. D. Christensen, K. U. Jansen, and S. W. Ludmerer. 2001. A novel human papillomavirus type 6 neutralizing domain comprising two discrete regions of the major capsid protein L1. Virology 289:262-268.
36. Michael, K. M., T. Waterboer, P. Sehr, A. Rother, U. Reidel, H. Boeing, I. G. Bravo, J. Schlehofer, B. C. Gartner, and M. Pawlita. 2008. Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog. 4:e1000091.
37. Mirza, I. H., T. J. Wilkin, M. Cantarini, and K. Moore. 1987. A comparison of spleen and lymph node cells as fusion partners for the raising of mono-clonal antibodies after different routes of immunisation. J. Immunol. Methods 105:235-243.
38. Muller, M., L. Gissmann, R. J. Cristiano, X. Y. Sun, I. H. Frazer, A. B. Jenson, A. Alonso, H. Zentgraf, and J. Zhou. 1995. Papillomavirus capsid binding and uptake by cells from different tissues and species. J. Virol. 69:948-954.
39. Muller, M., J. Zhou, T. D. Reed, C. Rittmuller, A. Burger, J. Gabelsberger, J. Braspenning, and L. Gissmann. 1997. Chimeric papillomavirus-like particles. Virology 234:93-111.
40. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
41. Pinto, L. A., P. E. Castle, R. B. Roden, C. D. Harro, D. R. Lowy, J. T. Schiller, D. Wallace, M. Williams, W. Kopp, I. H. Frazer, J. A. Berzofsky, and A. Hildesheim. 2005. HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood. Vaccine 23:3555-3564.
42. Rizk, R. Z., N. D. Christensen, K. M. Michael, M. Muller, P. Sehr, T. Waterboer, and M. Pawlita. 2008. Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types. J. Gen. Virol. 89:117-129.
43. Roden, R. B., A. Armstrong, P. Haderer, N. D. Christensen, N. L. Hubbert, D. R. Lowy, J. T. Schiller, and R. Kirnbauer. 1997. Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope. J. Virol. 71:6247-6252. (Pubitemid 27304974)
44. Samorski, R., L. Gissmann, and W. Osen. 2006. Codon optimized expression of HPV 16 E6 renders target cells susceptible to E6-specific CTL recognition. Immunol. Lett. 107:41-49.
45. Sapp, M., C. Fligge, I. Petzak, J. R. Harris, and R. E. Streeck. 1998. Papillomavirus assembly requires trimerization of the major capsid protein by disulfides between two highly conserved cysteines. J. Virol. 72:6186-6189. (Pubitemid 28283413)
46. Scibienski, R. J. 1973. Denaturation of lysozyme by Freund's complete adjuvant. J. Immunol. 111:114-120.
47. Sehr, P., M. Muller, R. Hopfl, A. Widschwendter, and M. Pawlita. 2002. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J. Virol. Methods 106:61-70. (Pubitemid 35279650)
48. Sehr, P., K. Zumbach, and M. Pawlita. 2001. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J. Immunol. Methods 253:153-162. (Pubitemid 32522523)
49. Snapper, C. M., and W. E. Paul. 1987. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944-947.
50. Strickler, H. D., A. Hildesheim, R. P. Viscidi, K. V. Shah, B. Goebel, J. Drummond, D. Waters, Y. Sun, N. L. Hubbert, S. Wacholder, L. A. Brinton, C. L. Han, P. C. Nasca, R. McClimens, K. Turk, V. Devairakkam, S. Leitman, C. Martin, and J. T. Schiller. 1997. Interlaboratory agreement among results of human papillomavirus type 16 enzyme-linked immunosorbent assays. J. Clin. Microbiol. 35:1751-1756.
51. Tannous, B. A., D. E. Kim, J. L. Fernandez, R. Weissleder, and X. O. Breakefield. 2005. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol. Ther. 11:435-443.
52. Thönes, N., A. Herreiner, L. Schädlich, K. Piuko, and M. Müller. 2008. A direct comparison of human papillomavirus type 16 L1 particles reveals a lower immunogenicity of capsomeres than viruslike particles with respect to the induced antibody response. J. Virol. 82:5472-5485. (Pubitemid 351705254)
53. Waterboer, T., D. Abeni, F. Sampogna, A. Rother, C. Masini, P. Sehr, K. M. Michael, and M. Pawlita. 2008. Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin. Br. J. Dermatol. 159:457-459.
54. Waterboer, T., P. Sehr, K. M. Michael, S. Franceschi, J. D. Nieland, T. O. Joos, M. F. Templin, and M. Pawlita. 2005. Multiplex human papillomavirus serology based on in situ-purified glutathione S-transferase fusion proteins. Clin. Chem. 51:1845-1853.
55. Waterboer, T., P. Sehr, and M. Pawlita. 2006. Suppression of non-specific binding in serological Luminex assays. J. Immunol. Methods 309:200-204. (Pubitemid 43190816)
56. White, W. I., S. D. Wilson, F. J. Palmer-Hill, R. M. Woods, S. J. Ghim, L. A. Hewitt, D. M. Goldman, S. J. Burke, A. B. Jenson, S. Koenig, and J. A. Suzich. 1999. Characterization of a major neutralizing epitope on human papillomavirus type 16 L1. J. Virol. 73:4882-4889.
57. Wikstrom, A., G. J. van Doornum, W. G. Quint, J. T. Schiller, and J. Dillner. 1995. Identification of human papillomavirus seroconversions. J. Gen. Virol. 76(Pt. 3):529-539.
58. Yang, R., C. M. Wheeler, X. Chen, S. Uematsu, K. Takeda, S. Akira, D. V. Pastrana, R. P. Viscidi, and R. B. Roden. 2005. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer. J. Virol. 79:6741-6750.